Two RSV Shots to Carry Neurological Risk Warning

GSK and Pfizer’s respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration said on Tuesday. The regulator conducted a postmarketing trial which suggested…[#item_full_content]